US Stock MarketDetailed Quotes

REGEN BIOPHARMA INC (RGBPP)

Watchlist
  • 0.0041
  • 0.00000.00%
15min DelayClose Apr 14 10:44 ET
0Market Cap0.00P/E (TTM)

REGEN BIOPHARMA INC (RGBPP) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2025
(FY)Sep 30, 2025
(Q4)Sep 30, 2025
(Q3)Jun 30, 2025
(Q2)Mar 31, 2025
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-198.20%-197.94K
48.96%-383.59K
22.81%-160.01K
67.57%-55.98K
51.64%-101.23K
59.11%-66.38K
-332.12%-751.54K
-785.70%-207.29K
-98.36%-172.59K
-294.64%-209.32K
Net income from continuing operations
-87.79%-967.85K
-90.72%-1.27M
-111.44%-572.47K
-28.57%-167.29K
84.20%-19.36K
-255.65%-515.38K
-157.78%-668.26K
16.70%-270.75K
-31.15%-130.12K
-122.77%-122.47K
Operating gains losses
----
16,416.58%675.53K
----
----
----
----
100.19%4.09K
----
----
----
Other non cash items
-29.98%8.85K
54.72%180.25K
56.91%162.33K
-269.72%-7.36K
191.36%12.64K
189.35%12.64K
-53.35%116.5K
-58.76%103.46K
477.30%4.34K
--4.34K
Change In working capital
-16.26%361.06K
113.81%35.14K
-248.61%-321.68K
141.05%20.17K
-3.65%-94.51K
2,078.63%431.16K
-213.95%-254.38K
-104.19%-92.28K
-502.39%-49.13K
-4,807.59%-91.19K
-Change in receivables
-0.00%-27.43K
-15.94%-110K
0.00%-27.73K
-0.01%-27.43K
0.01%-27.42K
-123.00%-27.42K
-137.31%-94.87K
-149.03%-27.73K
-221.48%-27.43K
-152.16%-27.43K
-Change in prepaid assets
----
225.95%47.56K
--0
-279.28%-28.45K
25,392.50%50.99K
400.46%25.02K
-280.27%-37.76K
-667.08%-35.46K
-163.26%-7.5K
-89.24%200
-Change in payables and accrued expense
-20.10%39.3K
773.33%174.13K
2,174.13%63.99K
7.29%18.42K
231.58%42.53K
52.41%49.19K
-66.47%19.94K
-81.67%2.81K
82.31%17.17K
-314.15%-32.32K
-Change in other current liabilities
-8.46%380.83K
--50K
-124,923.75%-326.31K
34,098.85%89.26K
---128.96K
--416.02K
--0
---261
--261
----
-Change in other working capital
0.00%-31.64K
10.68%-126.56K
0.00%-31.64K
0.00%-31.64K
0.00%-31.64K
32.35%-31.64K
-27.15%-141.69K
-91.61%-31.64K
0.00%-31.64K
0.00%-31.64K
Cash from discontinued investing activities
Operating cash flow
-198.20%-197.94K
48.96%-383.59K
22.81%-160.01K
67.57%-55.98K
51.64%-101.23K
59.11%-66.38K
-332.12%-751.54K
-785.66%-207.29K
-98.36%-172.59K
-294.64%-209.32K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
102.08%132.96K
-28.32%452.43K
55.86%227.8K
-64.19%55.98K
-36.87%102.86K
-60.31%65.8K
158.96%631.22K
1.67%146.16K
156.32K
62.94%162.94K
Net issuance payments of debt
--0
410.02%344.23K
1.36%119.6K
166.58%55.98K
511.42%102.86K
241.50%65.8K
-72.31%67.49K
-17.92%118K
--21K
-125.00%-25K
Net common stock issuance
--191.8K
-89.68%58.2K
106.66%58.2K
--0
----
----
--563.72K
--28.16K
--135.33K
--187.94K
Net other financing activities
---58.84K
--50K
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
102.08%132.96K
-28.32%452.43K
55.86%227.8K
-64.19%55.98K
-36.87%102.86K
-60.31%65.8K
158.96%631.22K
1.67%146.16K
--156.32K
62.94%162.94K
Net cash flow
Beginning cash position
9,614.39%69.56K
-99.41%716
-97.15%1.76K
-97.75%1.76K
-99.89%135
-99.41%716
136.38%121.04K
8,837.57%61.85K
-10.93%78.11K
205.58%124.5K
Current changes in cash
-11,083.65%-64.98K
157.21%68.84K
210.90%67.79K
--0
103.51%1.63K
-116.79%-581
-272.30%-120.32K
-150.80%-61.13K
81.31%-16.27K
-198.77%-46.38K
End cash Position
3,291.11%4.58K
9,614.39%69.56K
9,614.39%69.56K
-97.15%1.76K
-97.75%1.76K
-99.89%135
-99.41%716
-99.41%716
8,837.57%61.85K
-10.93%78.11K
Free cash flow
-198.20%-197.94K
48.96%-383.59K
22.81%-160.01K
67.57%-55.98K
51.64%-101.23K
59.11%-66.38K
-332.12%-751.54K
-785.66%-207.29K
-98.36%-172.59K
-294.64%-209.32K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Dec 31, 2025(FY)Sep 30, 2025(Q4)Sep 30, 2025(Q3)Jun 30, 2025(Q2)Mar 31, 2025(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -198.20%-197.94K48.96%-383.59K22.81%-160.01K67.57%-55.98K51.64%-101.23K59.11%-66.38K-332.12%-751.54K-785.70%-207.29K-98.36%-172.59K-294.64%-209.32K
Net income from continuing operations -87.79%-967.85K-90.72%-1.27M-111.44%-572.47K-28.57%-167.29K84.20%-19.36K-255.65%-515.38K-157.78%-668.26K16.70%-270.75K-31.15%-130.12K-122.77%-122.47K
Operating gains losses ----16,416.58%675.53K----------------100.19%4.09K------------
Other non cash items -29.98%8.85K54.72%180.25K56.91%162.33K-269.72%-7.36K191.36%12.64K189.35%12.64K-53.35%116.5K-58.76%103.46K477.30%4.34K--4.34K
Change In working capital -16.26%361.06K113.81%35.14K-248.61%-321.68K141.05%20.17K-3.65%-94.51K2,078.63%431.16K-213.95%-254.38K-104.19%-92.28K-502.39%-49.13K-4,807.59%-91.19K
-Change in receivables -0.00%-27.43K-15.94%-110K0.00%-27.73K-0.01%-27.43K0.01%-27.42K-123.00%-27.42K-137.31%-94.87K-149.03%-27.73K-221.48%-27.43K-152.16%-27.43K
-Change in prepaid assets ----225.95%47.56K--0-279.28%-28.45K25,392.50%50.99K400.46%25.02K-280.27%-37.76K-667.08%-35.46K-163.26%-7.5K-89.24%200
-Change in payables and accrued expense -20.10%39.3K773.33%174.13K2,174.13%63.99K7.29%18.42K231.58%42.53K52.41%49.19K-66.47%19.94K-81.67%2.81K82.31%17.17K-314.15%-32.32K
-Change in other current liabilities -8.46%380.83K--50K-124,923.75%-326.31K34,098.85%89.26K---128.96K--416.02K--0---261--261----
-Change in other working capital 0.00%-31.64K10.68%-126.56K0.00%-31.64K0.00%-31.64K0.00%-31.64K32.35%-31.64K-27.15%-141.69K-91.61%-31.64K0.00%-31.64K0.00%-31.64K
Cash from discontinued investing activities
Operating cash flow -198.20%-197.94K48.96%-383.59K22.81%-160.01K67.57%-55.98K51.64%-101.23K59.11%-66.38K-332.12%-751.54K-785.66%-207.29K-98.36%-172.59K-294.64%-209.32K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 102.08%132.96K-28.32%452.43K55.86%227.8K-64.19%55.98K-36.87%102.86K-60.31%65.8K158.96%631.22K1.67%146.16K156.32K62.94%162.94K
Net issuance payments of debt --0410.02%344.23K1.36%119.6K166.58%55.98K511.42%102.86K241.50%65.8K-72.31%67.49K-17.92%118K--21K-125.00%-25K
Net common stock issuance --191.8K-89.68%58.2K106.66%58.2K--0----------563.72K--28.16K--135.33K--187.94K
Net other financing activities ---58.84K--50K--------------------------------
Cash from discontinued financing activities
Financing cash flow 102.08%132.96K-28.32%452.43K55.86%227.8K-64.19%55.98K-36.87%102.86K-60.31%65.8K158.96%631.22K1.67%146.16K--156.32K62.94%162.94K
Net cash flow
Beginning cash position 9,614.39%69.56K-99.41%716-97.15%1.76K-97.75%1.76K-99.89%135-99.41%716136.38%121.04K8,837.57%61.85K-10.93%78.11K205.58%124.5K
Current changes in cash -11,083.65%-64.98K157.21%68.84K210.90%67.79K--0103.51%1.63K-116.79%-581-272.30%-120.32K-150.80%-61.13K81.31%-16.27K-198.77%-46.38K
End cash Position 3,291.11%4.58K9,614.39%69.56K9,614.39%69.56K-97.15%1.76K-97.75%1.76K-99.89%135-99.41%716-99.41%7168,837.57%61.85K-10.93%78.11K
Free cash flow -198.20%-197.94K48.96%-383.59K22.81%-160.01K67.57%-55.98K51.64%-101.23K59.11%-66.38K-332.12%-751.54K-785.66%-207.29K-98.36%-172.59K-294.64%-209.32K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
US President Trump stated in a recent interview that the US war with Iran has 'ended.' According to Axios, Pakistan, Egypt, and Turkey have Show More